Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
90.37
-1.50 (-1.63%)
At close: Jan 23, 2026, 4:00 PM EST
90.47
+0.10 (0.11%)
After-hours: Jan 23, 2026, 7:53 PM EST
Structure Therapeutics Market Cap
Structure Therapeutics has a market cap or net worth of $6.25 billion as of January 23, 2026. Its market cap has increased by 296.79% in one year.
Market Cap
6.25B
Enterprise Value
5.46B
1-Year Change
296.79%
Ranking
Category
Stock Price
$90.37
Market Cap Chart
Since the IPO on February 3, 2023, Structure Therapeutics's market cap has increased from $548.82M to $6.25B, an increase of 1,038.45%. That is a compound annual growth rate of 126.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 6.35B | 32.09% |
| Dec 31, 2025 | 4.81B | 209.65% |
| Dec 31, 2024 | 1.55B | -22.02% |
| Dec 29, 2023 | 1.99B | 262.83% |
| Feb 3, 2023 | 548.82M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rhythm Pharmaceuticals | 7.24B |
| Vaxcyte | 7.05B |
| ImmunityBio | 6.92B |
| PTC Therapeutics | 6.16B |
| Cogent Biosciences | 6.09B |
| Belite Bio | 5.98B |
| Kymera Therapeutics | 5.77B |
| CRISPR Therapeutics AG | 5.62B |